Phytomedicine
Volume 14, Issue 7 , Pages 546-550 , 6 August 2007

Inhibitors of aldose reductase and advanced glycation end-products formation from the leaves of Stelechocarpus cauliflorus R.E. Fr.

  • L. Wirasathien

      Affiliations

    • Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand
    • ,
  • T. Pengsuparp

      Affiliations

    • Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand
    • ,
  • R. Suttisri

      Affiliations

    • Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand
    • Corresponding Author InformationCorresponding author. Tel.: +662022188353; fax: +662022188354.
    • ,
  • H. Ueda

      Affiliations

    • Kobe Pharmaceutical University, 4-19-1 Motoyamakitamachi, Higashinada-ku, Kobe 658-8558, Japan
    • ,
  • M. Moriyasu

      Affiliations

    • Kobe Pharmaceutical University, 4-19-1 Motoyamakitamachi, Higashinada-ku, Kobe 658-8558, Japan
    • ,
  • K. Kawanishi

      Affiliations

    • Kobe Pharmaceutical University, 4-19-1 Motoyamakitamachi, Higashinada-ku, Kobe 658-8558, Japan

References 

  1. Ahmed N. Advanced glycation endproducts – role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 2005;67:3–21
  2. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J. Hypertens. 2003;21:3–12
  3. De Britto J, Manickam VS, Gopalakrishnan S, Ushioda T, Tanaka N. Determination of aglycone chirality in dihydroflavonol 3-O-α-l-rhamnosides by 1H-NMR spectroscopy. Chem. Pharm. Bull. 1995;43:338–339
  4. de la Fuente JA, Manzanaro S. Aldose reductase inhibitors from natural sources. Nat. Prod. Rep. 2003;20:243–251
  5. Gaffield W, Waiss AC. Structural relationships and interconversions of isomeric astilbins. J. Org. Chem. 1975;40:1057–1061
  6. Haraguchi H, Mochida Y, Sakai S, Masuda H, Tamura Y, Mizutani K, et al. Protection against oxidative damage by dihydroflavonols in Engelhardtia chrysolepis. Biosci. Biotechnol. Biochem. 1996;60:945–948
  7. Haraguchi H, Ohmi I, Masuda H, Tamura Y, Mizutani K, Tanaka O, et al. Inhibition of aldose reductase by dihydroflavonols in Engelhardtia chrysolepis and effects on other enzymes. Experientia. 1996;52:564–567
  8. Haraguchi H, Ohmi I, Fukuda A, Tamura Y, Mizutani K, Tanaka O, et al. Inhibition of aldose reductase and sorbitol accumulation by astilbin and taxifolin dihydroflavonols in Engelhardtia chrysolepis. Biosci. Biotechnol. Biochem. 1997;61:651–654
  9. Kador PF, Kinoshita JH, Sharpless NE. Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications. J. Med. Chem. 1985;28:841–849
  10. Matsuura N, Aradate T, Sasaki C, Kojima H, Ohara M, Hasegawa J, et al. Screening system for the Maillard reaction inhibitor from natural product extracts. J. Health Sci. 2002;48:520–526
  11. Morimitsu Y, Yoshida K, Esaki S, Hirota A. Protein glycation inhibitors from thyme (Thymus vulgaris). Biosci. Biotechnol. Biochem. 1995;59:2018–2021
  12. Nagasawa T, Tabata N, Ito Y, Nishizawa N, Aiba Y, Kitts DD. Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivative. Mol. Cell Biochem. 2003;249:3–10
  13. Nishimura C, Yamaoka T, Mizutani M, Yamashita K, Akera T, Tanimoto T. Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. Biochim. Biophys. Acta. 1991;1078:171–178
  14. Okuda J, Miwa I, Inagaki K, Horie T, Nakayama M. Inhibition of aldose reductases from rat and bovine lenses by flavonoids. Biochem. Pharmacol. 1982;31:3807–3822
  15. Silva DHS, Yoshida M, Kato MJ. Flavonoids from Iryanthera sagotiana. Phytochemistry. 1997;46:579–582
  16. Thomas MC, Baynes JW, Thorpe SR, Cooper ME. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr. Drug Targets. 2005;6:453–474
  17. Varma SD, Kinoshita JH. Inhibition of lens aldose reductase by flavonoids – their possible role in the prevention of diabetic cataracts. Biochem. Pharmacol. 1976;25:2505–2513
  18. Wada R, Yagihashi S. Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann. N.Y. Acad. Sci. 2005;1043:598–604
  19. Wautier JL, Guillausseau PJ. Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab. 2001;27:535–542
  20. Yamagishi S, Imaizumi T. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr. Pharm. Des. 2005;11:2279–2299

PII: S0944-7113(06)00128-0

doi: 10.1016/j.phymed.2006.09.001

Phytomedicine
Volume 14, Issue 7 , Pages 546-550 , 6 August 2007

Article Tools

* Image Usage & Resolution